BSLN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Basilea Pharmaceutica AG

Watchlist Manager

Watchlist

Price: 65.1 CHF -0.46% Market Closed

Market Cap: CHf789.1m

	Basilea Pharmaceutica AG SIX:BSLN	CH
B	Bharat Wire Ropes Ltd NSE:BHARATWIRE	IN
	Heidelberger Beteiligungsholding AG F:IPOK	DE
I	Inflection Point Acquisition Corp II NASDAQ:IPXX	US
K	KGHM Polska Miedz SA XBER:KGHA	PL
A	Abrdn PLC F:T3V2	UK
	Marlowe PLC LSE:MRL	UK
B	Bualuang Office Leasehold Real Estate Investment Trust SET:B-WORK	TH
A	Arara Inc TSE:4015	JP

Profitability Summary

Basilea Pharmaceutica AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

89% > 88%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

37% > 24%

Healthy Net Margin

21%

Sustainable 3Y Average Net Margin

19%

Declining Net Margin

32% > 21%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

22%

Free Cash Flow Margin is Increasing

16% > 22%

Exceptional ROE

39%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

40%

Declining ROIC

56% > 48%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.